Fabrication of active targeting lipid nanoparticles: Challenges and perspectives

Mullard, 2022, What's next for the synthetic lethality drug discovery engine?, Nat. Rev. Drug Discov., 21, 477, 10.1038/d41573-022-00107-0 Lin, 2015, Active targeting of nano-photosensitizer delivery systems for photodynamic therapy of cancer stem cells, J. Biomed. Nanotechnol., 11, 531, 10.1166/jbn.2015.2090 Kang, 2019, Enhanced subcellular trafficking of resveratrol using mitochondriotropic liposomes in cancer cells, Pharmaceutics, 11, 423, 10.3390/pharmaceutics11080423 Katayama, 2019, A mitochondrial delivery system using liposome-based nanocarriers that target myoblast cells, Mitochondrion, 49, 66, 10.1016/j.mito.2019.07.005 Xu, 2021, Hyaluronic acid coated liposomes Co-delivery of natural cyclic peptide RA-XII and mitochondrial targeted photosensitizer for highly selective precise combined treatment of colon cancer, Int. J. Nanomed., 16, 4929, 10.2147/IJN.S311577 Wang, 2021, Curcumin-loaded liposomes with the hepatic and lysosomal dual-targeted effects for therapy of hepatocellular carcinoma, Int. J. Pharm., 602, 10.1016/j.ijpharm.2021.120628 Dang, 2021, Nuclear targeted peptide combined with gambogic acid for synergistic treatment of breast cancer, Front. Chem., 9 Qin, 2021, Oxygen nanocarrier broke the hypoxia trap of solid tumors and rescued transfection efficiency for gene therapy, J. Nanobiotechnol., 19, 427, 10.1186/s12951-021-01144-4 Hashida, 2022, Advocation and advancements of EPR effect theory in drug delivery science: a commentary, J. Contr. Release, 346, 355, 10.1016/j.jconrel.2022.04.031 Zhang, 2019, Brain-targeted drug delivery by manipulating protein corona functions, Nat. Commun., 10, 3561, 10.1038/s41467-019-11593-z Qin, 2021, Development of a cancer vaccine using in vivo click-chemistry-mediated active lymph node accumulation for improved immunotherapy, Adv. Mater., 33, e2006007, 10.1002/adma.202006007 Melamed, 2022, Lipid nanoparticle chemistry determines how nucleoside base modifications alter mRNA delivery, J. Contr. Release, 341, 206, 10.1016/j.jconrel.2021.11.022 Fu, 2019, EphA2-Receptor targeted PEGylated nanoliposomes for the treatment of BRAF(V600E) mutated parent- and vemurafenib-resistant melanoma, Pharmaceutics, 11, 504, 10.3390/pharmaceutics11100504 Dolgin, 2021, The tangled history of mRNA vaccines, Nature, 597, 318, 10.1038/d41586-021-02483-w Shan, 2022, Current approaches of nanomedicines in the market and various stage of clinical translation, Acta Pharm. Sin. B, 12, 3028, 10.1016/j.apsb.2022.02.025 Beltrán-Gracia, 2019, Nanomedicine review: clinical developments in liposomal applications, Cancer Nanotech, 10, 10.1186/s12645-019-0055-y Guo, 2022, Folate-modified triptolide liposomes target activated macrophages for safe rheumatoid arthritis therapy, Biomater. Sci., 10, 499, 10.1039/D1BM01520F Xi, 2022, Enhanced uptake and anti-maturation effect of celastrol-loaded mannosylated liposomes on dendritic cells for psoriasis treatment, Acta Pharm. Sin. B, 12, 339, 10.1016/j.apsb.2021.07.019 Evers, 2022, Delivery of modified mRNA to damaged myocardium by systemic administration of lipid nanoparticles, J. Contr. Release, 343, 207, 10.1016/j.jconrel.2022.01.027 Zhang, 2021, A multiclade env-gag VLP mRNA vaccine elicits tier-2 HIV-1-neutralizing antibodies and reduces the risk of heterologous SHIV infection in macaques, Nat. Med., 27, 2234, 10.1038/s41591-021-01574-5 Singh, 2022, Smart and emerging nanomaterials-based biosensor for SARS-CoV-2 detection, Mater. Lett., 307, 10.1016/j.matlet.2021.131092 Nayak, 2022, Recent advancements of biogenic iron nanoparticles in cancer theranostics, Mater. Lett., 313, 10.1016/j.matlet.2022.131769 Adetunji, 2022, Potentialities of nanomaterials for the management and treatment of metabolic syndrome: a new insight, Materials Today Advances, 13, 10.1016/j.mtadv.2021.100198 Shrestha, 2019, X-ray induced photodynamic therapy with copper-cysteamine nanoparticles in mice tumors, Proc. Natl. Acad. Sci. U.S.A., 116, 16823, 10.1073/pnas.1900502116 Upadhyaya, 2014, The implications of recent advances in carboxymethyl chitosan based targeted drug delivery and tissue engineering applications, J. Contr. Release, 186, 54, 10.1016/j.jconrel.2014.04.043 Upadhyaya, 2013, Biomedical applications of carboxymethyl chitosans, Carbohydr. Polym., 91, 452, 10.1016/j.carbpol.2012.07.076 Ma, 2015, Screening of a specific peptide binding to esophageal squamous carcinoma cells from phage displayed peptide library, Mol. Cell. Probes, 29, 182, 10.1016/j.mcp.2015.04.001 Hofmeister, 2015, Phage-display-guided nanocarrier targeting to atheroprone vasculature, ACS Nano, 9, 4435, 10.1021/acsnano.5b01048 Gray, 2013, From phage display to nanoparticle delivery: functionalizing liposomes with multivalent peptides improves targeting to a cancer biomarker, Bioconjugate Chem., 24, 85, 10.1021/bc300498d van Rooy, 2012, Attaching the phage display-selected GLA peptide to liposomes: factors influencing target binding, Eur. J. Pharmaceut. Sci., 45, 330, 10.1016/j.ejps.2011.11.015 Lei, 2022, ALPPL2-Binding peptide facilitates targeted mRNA delivery for efficient hepatocellular carcinoma gene therapy, Adv. Funct. Mater. Yu, 2021, Mannose-modified liposome designed for epitope peptide drug delivery in cancer immunotherapy, Int. Immunopharm., 101, 10.1016/j.intimp.2021.108148 Zhao, 2020, Mannose-modified liposome Co-delivery of human papillomavirus type 16 E7 peptide and CpG oligodeoxynucleotide adjuvant enhances antitumor activity against established large TC-1 grafted tumors in mice, Int. J. Nanomed., 15, 9571, 10.2147/IJN.S275670 Nakamura, 2022, Extrahepatic targeting of lipid nanoparticles in vivo with intracellular targeting for future nanomedicines, Adv. Drug Deliv. Rev., 188, 10.1016/j.addr.2022.114417 Zhao, 2020, Targeting strategies for tissue-specific drug delivery, Cell, 181, 151, 10.1016/j.cell.2020.02.001 Mojarad-Jabali, 2021, An update on actively targeted liposomes in advanced drug delivery to glioma, Int. J. Pharm., 602, 10.1016/j.ijpharm.2021.120645 Lima, 2021, Liposome surface modification by phospholipid chemical reactions, Chem. Phys. Lipids, 237, 10.1016/j.chemphyslip.2021.105084 Wang, 2017, A novel immunoliposome mediated by CD123 antibody targeting to acute myeloid leukemia cells, Int. J. Pharm., 529, 531, 10.1016/j.ijpharm.2017.06.003 Li, 2018, pH-sensitive folic acid and dNP2 peptide dual-modified liposome for enhanced targeted chemotherapy of glioma, Eur. J. Pharmaceut. Sci., 124, 240, 10.1016/j.ejps.2018.07.055 Yoon, 2019, Intravesical delivery of rapamycin via folate-modified liposomes dispersed in thermo-reversible hydrogel, Int. J. Nanomed., 14, 6249, 10.2147/IJN.S216432 Gai, 2020, MT1DP loaded by folate-modified liposomes sensitizes erastin-induced ferroptosis via regulating miR-365a-3p/NRF2 axis in non-small cell lung cancer cells, Cell Death Dis., 11, 751, 10.1038/s41419-020-02939-3 Jhaveri, 2018, Transferrin-targeted, resveratrol-loaded liposomes for the treatment of glioblastoma, J. Contr. Release, 277, 89, 10.1016/j.jconrel.2018.03.006 Mojarad-Jabali, 2022, Comparison of three synthetic transferrin mimetic small peptides to promote the blood-brain barrier penetration of vincristine liposomes for improved glioma targeted therapy, Int. J. Pharm., 613, 10.1016/j.ijpharm.2021.121395 Wen, 2018, Anticancer efficacy of targeted shikonin liposomes modified with RGD in breast cancer cells, Molecules, 23, 10.3390/molecules23020268 Sun, 2019, Tumor targeting DVDMS-nanoliposomes for an enhanced sonodynamic therapy of gliomas, Biomater. Sci., 7, 985, 10.1039/C8BM01187G Wu, 2020, Near-infrared fluorescence imaging-guided focused ultrasound-mediated therapy against Rheumatoid Arthritis by MTX-ICG-loaded iRGD-modified echogenic liposomes, Theranostics, 10, 10092, 10.7150/thno.44865 Wang, 2019, Liposomes with cyclic RGD peptide motif triggers acute immune response in mice, J. Contr. Release, 293, 201, 10.1016/j.jconrel.2018.12.003 Li, 2021, A pentapeptide enabled AL3810 liposome-based glioma-targeted therapy with immune opsonic effect attenuated, Acta Pharm. Sin. B, 11, 283, 10.1016/j.apsb.2020.07.024 Jin, 2020, Size-adaptable and ligand (biotin)-sheddable nanocarriers equipped with avidin scavenging technology for deep tumor penetration and reduced toxicity, J. Contr. Release, 320, 142, 10.1016/j.jconrel.2020.01.040 Yamashita, 2018, Development of PEGylated aspartic acid-modified liposome as a bone-targeting carrier for the delivery of paclitaxel and treatment of bone metastasis, Biomaterials, 154, 74, 10.1016/j.biomaterials.2017.10.053 Li, 2020, Sialic acid-conjugate modified liposomes targeting neutrophils for improved tumour therapy, Biomater. Sci., 8, 2189, 10.1039/C9BM01732A Lai, 2021, Dual targeting single arrow: neutrophil-targeted sialic acid-modified nanoplatform for treating comorbid tumors and rheumatoid arthritis, Int. J. Pharm., 607, 10.1016/j.ijpharm.2021.121022 Wang, 2020, Influences of galactose ligand on the uptake of TADF liposomes by HepG(2) cells, Photodiagnosis Photodyn. Ther., 32, 10.1016/j.pdpdt.2020.102014 Li, 2021, N-acetylgalactosamine-decorated nanoliposomes for targeted delivery of paclitaxel to hepatocellular carcinoma, Eur. J. Med. Chem., 222, 10.1016/j.ejmech.2021.113605 Diao, 2019, Co-delivery of dihydroartemisinin and HMGB1 siRNA by TAT-modified cationic liposomes through the TLR4 signaling pathway for treatment of lupus nephritis, Int. J. Nanomed., 14, 8627, 10.2147/IJN.S220754 Jung, 2019, A peptide probe enables photoacoustic-guided imaging and drug delivery to lung tumors in K-ras(LA2) mutant mice, Cancer Res., 79, 4271, 10.1158/0008-5472.CAN-18-3089 Kuznetsova, 2019, Mitochondria-targeted cationic liposomes modified with alkyltriphenylphosphonium bromides loaded with hydrophilic drugs: preparation, cytotoxicity and colocalization assay, J. Mater. Chem. B, 7, 7351, 10.1039/C9TB01853K Jiang, 2021, Self-adjuvant effect by manipulating the bionano interface of liposome-based nanovaccines, Nano Lett., 21, 4744, 10.1021/acs.nanolett.1c01133 Moghimipour, 2018, Folic acid-modified liposomal drug delivery strategy for tumor targeting of 5-fluorouracil, Eur. J. Pharmaceut. Sci., 114, 166, 10.1016/j.ejps.2017.12.011 Wang, 2020, Ultrasound-targeted microbubble destruction augmented synergistic therapy of rheumatoid arthritis via targeted liposomes, J. Mater. Chem. B, 8, 5245, 10.1039/D0TB00430H Yang, 2020, Dual-targeting liposome modified by glutamic hexapeptide and folic acid for bone metastatic breast cancer, Chem. Phys. Lipids, 228, 10.1016/j.chemphyslip.2020.104882 Sun, 2018, Hepatocellular carcinoma-targeted effect of configurations and groups of glycyrrhetinic acid by evaluation of its derivative-modified liposomes, Int. J. Nanomed., 13, 1621, 10.2147/IJN.S153944 Yin, 2018, Dual receptor recognizing liposomes containing paclitaxel and hydroxychloroquine for primary and metastatic melanoma treatment via autophagy-dependent and independent pathways, J. Contr. Release, 288, 148, 10.1016/j.jconrel.2018.08.015 Zhao, 2018, Targeted therapy of intracranial glioma model mice with curcumin nanoliposomes, Int. J. Nanomed., 13, 1601, 10.2147/IJN.S157019 Huang, 2020, Biotin and glucose dual-targeting, ligand-modified liposomes promote breast tumor-specific drug delivery, Bioorg. Med. Chem. Lett., 30, 10.1016/j.bmcl.2020.127151 Santiwarangkool, 2019, A study of the endocytosis mechanism and transendothelial activity of lung-targeted GALA-modified liposomes, J. Contr. Release, 307, 55, 10.1016/j.jconrel.2019.06.009 Cannito, 2022, Hyaluronated and PEGylated liposomes as a potential drug-delivery strategy to specifically target liver cancer and inflammatory cells, Molecules, 27, 10.3390/molecules27031062 Zhang, 2021, Chondroitin sulfate-modified liposomes for targeted Co-delivery of doxorubicin and retinoic acid to suppress breast cancer lung metastasis, Pharmaceutics, 13, 406, 10.3390/pharmaceutics13030406 Xin, 2021, Efficient anti-glioma therapy through the brain-targeted RVG15-modified liposomes loading paclitaxel-cholesterol complex, Int. J. Nanomed., 16, 5755, 10.2147/IJN.S318266 Zhao, 2019, Dual-active targeting liposomes drug delivery system for bone metastatic breast cancer: synthesis and biological evaluation, Chem. Phys. Lipids, 223, 10.1016/j.chemphyslip.2019.104785 Wu, 2020, Fluorescence imaging-guided multifunctional liposomes for tumor-specific phototherapy for laryngeal carcinoma, Biomater. Sci., 8, 3443, 10.1039/D0BM00249F Chen, 2018, Transferrin and folic acid co-modified bufalin-loaded nanoliposomes: preparation, characterization, and application in anticancer activity, Int. J. Nanomed., 13, 6009, 10.2147/IJN.S176012 Tang, 2019, Gemcitabine-loaded RGD modified liposome for ovarian cancer: preparation, characterization and pharmacodynamic studies, Drug Des. Dev. Ther., 13, 3281, 10.2147/DDDT.S211168 Li, 2022, Preparation and pharmacokinetics of glycyrrhetinic acid and cell transmembrane peptides modified with liposomes for liver targeted-delivery, Biomed. Mater., 17, 10.1088/1748-605X/ac6b73 Liu, 2022, Targeted treprostinil delivery inhibits pulmonary arterial remodeling, Eur. J. Pharmacol., 923, 10.1016/j.ejphar.2021.174700 Woll, 2019, Sortagged anti-EGFR immunoliposomes exhibit increased cytotoxicity on target cells, Eur. J. Pharm. Biopharm., 136, 203, 10.1016/j.ejpb.2019.01.020 Ran, 2018, Microfluidic self-assembly of a combinatorial library of single- and dual-ligand liposomes for in vitro and in vivo tumor targeting, Eur. J. Pharm. Biopharm., 130, 1, 10.1016/j.ejpb.2018.06.017 Lv, 2021, One-step microfluidic fabrication of multi-responsive liposomes for targeted delivery of doxorubicin synergism with photothermal effect, Int. J. Nanomed., 16, 7759, 10.2147/IJN.S329621 Khaleseh, 2021, Enhancement of in vitro antitumour activity of epirubicin in HER2+ breast cancer cells using immunoliposome formulation, IET Nanobiotechnol., 15, 257, 10.1049/nbt2.12012 Zhou, J. E., et al.,Hepatic macrophage targeted siRNA lipid nanoparticles treat non-alcoholic steatohepatitis. J. Contr. Release 343 (2022), pp 175-186. Zhu, 2018, Preparation and characterization of norcantharidin liposomes modified with stearyl glycyrrhetinate, Exp. Ther. Med., 16, 1639 Yue, 2020, Liposomes co-delivery system of doxorubicin and astragaloside IV co-modified by folate ligand and octa-arginine polypeptide for anti-breast cancer, RSC Adv., 10, 11573, 10.1039/C9RA09040A Tang, 2020, Targeted delivery of zoledronic acid through the sialic acid - siglec axis for killing and reversal of M2 phenotypic tumor-associated macrophages - a promising cancer immunotherapy, Int. J. Pharm., 590, 10.1016/j.ijpharm.2020.119929 Lin, 2018, Dual-ligand modified liposomes provide effective local targeted delivery of lung-cancer drug by antibody and tumor lineage-homing cell-penetrating peptide, Drug Deliv., 25, 256, 10.1080/10717544.2018.1425777 Ding, 2021, Sialic acid conjugate-modified liposomes enable tumor homing of epirubicin via neutrophil/monocyte infiltration for tumor therapy, Acta Biomater., 134, 702, 10.1016/j.actbio.2021.07.063 Dos Santos Rodrigues, 2019, Development and screening of brain-targeted lipid-based nanoparticles with enhanced cell penetration and gene delivery properties, Int. J. Nanomed., 14, 6497, 10.2147/IJN.S215941 Lakkadwala, 2019, Dual functionalized liposomes for efficient co-delivery of anti-cancer chemotherapeutics for the treatment of glioblastoma, J. Contr. Release, 307, 247, 10.1016/j.jconrel.2019.06.033 Dos Santos Rodrigues, 2020, Efficient neuronal targeting and transfection using RVG and transferrin-conjugated liposomes, Brain Res., 1734, 10.1016/j.brainres.2020.146738 Dos Santos Rodrigues, 2020, In vitro and in vivo characterization of CPP and transferrin modified liposomes encapsulating pDNA, Nanomed. Nanotechnol. Biol. Med., 28, 10.1016/j.nano.2020.102225 Dos Santos Rodrigues, 2020, Dual-modified liposome for targeted and enhanced gene delivery into mice brain, J. Pharmacol. Exp. Therapeut., 374, 354, 10.1124/jpet.119.264127 Liang, 2021, Targeted-delivery of siRNA via a polypeptide-modified liposome for the treatment of gp96 over-expressed breast cancer, Mater. Sci. Eng. C Mater. Biol. Appl., 121, 10.1016/j.msec.2020.111847 Xie, 2021, Evaluation of nanoscaled dual targeting drug-loaded liposomes on inhibiting vasculogenic mimicry channels of brain glioma, Artif. Cell Nanomed. Biotechnol., 49, 596 Wang, 2022, Glioma-targeted multifunctional nanoparticles to co-deliver camptothecin and curcumin for enhanced chemo-immunotherapy, Biomater. Sci., 10, 1292, 10.1039/D1BM01987B Wu, 2022, All-stage targeted therapy for glioblastoma based on lipid membrane coated cabazitaxel nanocrystals, J. Contr. Release, 345, 685, 10.1016/j.jconrel.2022.03.047 Roveri, 2017, Prolonged circulation and increased tumor accumulation of liposomal vincristine in a mouse model of rhabdomyosarcoma, Nanomed. Nanotechnol. Biol. Med., 12, 1135 Belhadj, 2017, Design of Y-shaped targeting material for liposome-based multifunctional glioblastoma-targeted drug delivery, J. Contr. Release, 255, 132, 10.1016/j.jconrel.2017.04.006 Peng, 2018, Dual-targeting for brain-specific liposomes drug delivery system: synthesis and preliminary evaluation, Bioorg. Med. Chem., 26, 4677, 10.1016/j.bmc.2018.08.006 Ferhan, 2022, Lipid nanoparticle technologies for nucleic acid delivery: a nanoarchitectonics perspective, Adv. Funct. Mater., 32, 2203669, 10.1002/adfm.202203669 Wang, 2017, Targeted therapy of octreotide-modified oleanolic acid liposomes to somatostatin receptor overexpressing tumor cells, Nanomed. Nanotechnol. Biol. Med., 12(8), 927 Maja, 2020, Sustainable technologies for liposome preparation, J. Supercrit. Fluids, 165, 10.1016/j.supflu.2020.104984 Santo, 2014, Liposomes preparation using a supercritical fluid assisted continuous process, Chem. Eng. J., 249, 153, 10.1016/j.cej.2014.03.099 Bartheldyova, 2018, Bioconjugate Chem., 29, 2343, 10.1021/acs.bioconjchem.8b00311 AlSawaftah, 2021, Transferrin-modified liposomes triggered with ultrasound to treat HeLa cells, Sci. Rep., 11, 10.1038/s41598-021-90349-6 Yang, 2017, Therapeutic effects of long-circulating miR-135a-containing cationic immunoliposomes against gallbladder carcinoma, Sci. Rep., 7, 5982, 10.1038/s41598-017-06234-8 Zhang, 2019, Holo-lactoferrin modified liposome for relieving tumor hypoxia and enhancing radiochemotherapy of cancer, Small, 15, e1803703, 10.1002/smll.201803703 de Oliveira, 2020, Liposome-based nanocarrier loaded with a new quinoxaline derivative for the treatment of cutaneous leishmaniasis, Mater. Sci. Eng. C. Mater. Biol. Appl., 110, 10.1016/j.msec.2020.110720 Ye, 2020, Sorafenib-loaded long-circulating nanoliposomes for liver cancer therapy, BioMed Res. Int., 2020, 10.1155/2020/1351046 Hou, 2018, Novel SS-31 modified liposomes for improved protective efficacy of minocycline against drug-induced hearing loss, Biomater. Sci., 6, 1627, 10.1039/C7BM01181D Jiang, 2018, Enhanced antitumor and anti-metastasis efficacy against aggressive breast cancer with a fibronectin-targeting liposomal doxorubicin, J. Contr. Release, 271, 21, 10.1016/j.jconrel.2017.12.026 Deng, 2019, Tumors and their microenvironment dual-targeting chemotherapy with local immune adjuvant therapy for effective antitumor immunity against breast cancer, Adv. Sci., 6, 10.1002/advs.201801868 Shahraki, N., et al.,Preparation and characterization of PEGylated liposomal Doxorubicin targeted with leptin-derived peptide and evaluation of their anti-tumor effects, in vitro and in vivo in mice bearing C26 colon carcinoma. Colloids Surf. B Biointerfaces 200 (2021), p 111589. Lee, 2022, Fibroblast activation protein activated antifibrotic peptide delivery attenuates fibrosis in mouse models of liver fibrosis, Nat. Commun., 13, 1516, 10.1038/s41467-022-29186-8 Zhang, 2018, Pharmacokinetics, distribution and anti-tumor efficacy of liposomal mitoxantrone modified with a luteinizing hormone-releasing hormone receptor-specific peptide, Int. J. Nanomed., 13, 1097, 10.2147/IJN.S150512 Khayrani, 2019, Targeting ovarian cancer cells overexpressing CD44 with immunoliposomes encapsulating glycosylated paclitaxel, Int. J. Mol. Sci., 20, 10.3390/ijms20051042 Sun, 2019, CD123/CD33 dual-antibody modified liposomes effectively target acute myeloid leukemia cells and reduce antigen-negative escape, Int. J. Pharm., 568, 10.1016/j.ijpharm.2019.118518 Wang, 2019, Cell-Penetrating peptide and transferrin Co-modified liposomes for targeted therapy of glioma, Molecules, 24, 10.3390/molecules24193540 Lu, 2018, Antibody-modified liposomes for tumor-targeting delivery of timosaponin AIII, Int. J. Nanomed., 13, 1927, 10.2147/IJN.S153107 Pireddu, 2018, A novel lactoferrin-modified stealth liposome for hepatoma-delivery of triiodothyronine, Int. J. Pharm., 537, 257, 10.1016/j.ijpharm.2017.12.048 Ma, 2018, Development of docetaxel liposome surface modified with CD133 aptamers for lung cancer targeting, Artif. Cell Nanomed. Biotechnol., 46, 1864 Xie, 2021, Endoglin-aptamer-functionalized liposome-equipped PD-1-silenced T cells enhance antitumoral immunotherapeutic effects, Int. J. Nanomed., 16, 6017, 10.2147/IJN.S317220 Xiao, 2018, Vinorelbine cationic liposomes modified with wheat germ agglutinin for inhibiting tumor metastasis in treatment of brain glioma, Artif. Cell Nanomed. Biotechnol., 46, S524, 10.1080/21691401.2018.1501377 Hei, 2020, Multifunctional immunoliposomes combining catalase and PD-L1 antibodies overcome tumor hypoxia and enhance immunotherapeutic effects against melanoma, Int. J. Nanomed., 15, 1677, 10.2147/IJN.S225807 Bartheldyova, 2019, N-Oxy lipid-based click chemistry for orthogonal coupling of mannan onto nanoliposomes prepared by microfluidic mixing: synthesis of lipids, characterisation of mannan-coated nanoliposomes and in vitro stimulation of dendritic cells, Carbohydr. Polym., 207, 521, 10.1016/j.carbpol.2018.10.121 Ye, 2022, Antibody-targeted liposomes for enhanced targeting of the blood-brain barrier, Pharm. Res. (N. Y.), 39(7), 1523, 10.1007/s11095-022-03186-1 Zhao, 2020, A new tandem peptide modified liposomal doxorubicin for tumor "ecological therapy, Nanoscale, 12, 3359, 10.1039/C9NR09585C Mahmud, 2018, Targeting glioblastoma cells expressing CD44 with liposomes encapsulating doxorubicin and displaying chlorotoxin-IgG Fc fusion protein, Int. J. Mol. Sci., 19, 10.3390/ijms19030659 Kong, 2020, Tumor microenvironmental responsive liposomes simultaneously encapsulating biological and chemotherapeutic drugs for enhancing antitumor efficacy of NSCLC, Int. J. Nanomed., 15, 6451, 10.2147/IJN.S258906 Zhao, 2020, Lactoferrin-mediated macrophage targeting delivery and patchouli alcohol-based therapeutic strategy for inflammatory bowel diseases, Acta Pharm. Sin. B, 10, 1966, 10.1016/j.apsb.2020.07.019 Shimizu, 2021, New strategy for MS treatment with autoantigen-modified liposomes and their therapeutic effect, J. Contr. Release, 335, 389, 10.1016/j.jconrel.2021.05.027 Khoshnejad, 2018, Molecular engineering of antibodies for site-specific covalent conjugation using CRISPR/Cas9, Sci. Rep., 8, 1760, 10.1038/s41598-018-19784-2 So, 2017, Site-selective covalent reactions on proteinogenic amino acids, Curr. Opin. Biotechnol., 48, 220, 10.1016/j.copbio.2017.06.003 von Witting, 2021, Affinity-based methods for site-specific conjugation of antibodies, Bioconjugate Chem., 32, 1515, 10.1021/acs.bioconjchem.1c00313 Woll, 2019, Sortagging of liposomes with a murine CD11b-specific VHH increases in vitro and in vivo targeting specificity of myeloid cells, Eur. J. Pharm. Biopharm., 134, 190, 10.1016/j.ejpb.2018.11.014 Shim, 2019, Staphylococcus aureus-mimetic control of antibody orientation on nanoparticles, Nanomed. Nanotechnol. Biol. Med., 16, 267, 10.1016/j.nano.2018.09.007 Hirata, 2021, A simple, fast, and orientation-controllable technology for preparing antibody-modified liposomes, Int. J. Pharm., 607, 10.1016/j.ijpharm.2021.120966 Johnson, 2005, Controlling protein orientation at interfaces using histidine tags: an alternative to Ni/NTA, J. Am. Chem. Soc., 127, 2018, 10.1021/ja045084g Dubrovskaya, 2019, Vaccination with glycan-modified HIV NFL envelope trimer-liposomes elicits broadly neutralizing antibodies to multiple sites of vulnerability, Immunity, 51, 915, 10.1016/j.immuni.2019.10.008 Petrokova, 2019, Targeting human thrombus by liposomes modified with anti-fibrin protein binders, Pharmaceutics, 11, 642, 10.3390/pharmaceutics11120642 Liu, 2011, Tumor specific delivery and therapy by double-targeted nanostructured lipid carriers with anti-VEGFR-2 antibody, Mol. Pharm., 8, 2291, 10.1021/mp200402e Hayashi, 2018, Drug delivery using polyhistidine peptide-modified liposomes that target endogenous lysosome, Biochem. Biophys. Res. Commun., 501, 648, 10.1016/j.bbrc.2018.05.037 Sakurai, 2018, Effective therapy using a liposomal siRNA that targets the tumor vasculature in a model murine breast cancer with lung metastasis, Mol. Ther. Oncolytics, 11, 102, 10.1016/j.omto.2018.10.004 Zhang, 2021, A pH-sensitive T7 peptide-decorated liposome system for HER2 inhibitor extracellular delivery: an application for the efficient suppression of HER2+ breast cancer, J. Mater. Chem. B, 9, 8768, 10.1039/D1TB01619A Lei, 2019, Dual-functionalized liposome by co-delivery of paclitaxel with sorafenib for synergistic antitumor efficacy and reversion of multidrug resistance, Drug Deliv., 26, 262, 10.1080/10717544.2019.1580797 Zhang, 2022, Reversing tumor immunosuppressive microenvironment via targeting codelivery of CpG ODNs/PD-L1 peptide antagonists to enhance the immune checkpoint blockade-based anti-tumor effect, Eur. J. Pharmaceut. Sci., 168, 10.1016/j.ejps.2021.106044 Wei, 2021, Quercetin loaded liposomes modified with galactosylated chitosan prevent LPS/D-GalN induced acute liver injury, Mater. Sci. Eng. C. Mater. Biol. Appl., 131, 10.1016/j.msec.2021.112527 Zhang, 2021, Brain-targeted delivery of obidoxime, using aptamer-modified liposomes, for detoxification of organophosphorus compounds, J. Contr. Release, 329, 1117, 10.1016/j.jconrel.2020.10.039 Zhang, 2021, Hepatic stellate cells specific liposomes with the Toll-like receptor 4 shRNA attenuates liver fibrosis, J. Cell Mol. Med., 25, 1299, 10.1111/jcmm.16209 Grimsley, 2021, Liposomal nanocarriers designed for sub-endothelial matrix targeting under vascular flow conditions, Pharmaceutics, 13, 1816, 10.3390/pharmaceutics13111816 Sasaki, 2021, Alpha-dystroglycan binding peptide A2G80-modified stealth liposomes as a muscle-targeting carrier for Duchenne muscular dystrophy, J. Contr. Release, 329, 1037, 10.1016/j.jconrel.2020.10.032 Wu, 2020, Low molecular weight heparin modified bone targeting liposomes for orthotopic osteosarcoma and breast cancer bone metastatic tumors, Int. J. Biol. Macromol., 164, 2583, 10.1016/j.ijbiomac.2020.08.068 Ren, 2021, Resolving hepatic fibrosis via suppressing oxidative stress and an inflammatory response using a novel hyaluronic acid modified nanocomplex, Biomater. Sci., 9, 8259, 10.1039/D1BM01499D Abdelrehim, 2019, The use of tail-anchored protein chimeras to enhance liposomal cargo delivery, PLoS One, 14, e0212701, 10.1371/journal.pone.0212701 Leaman, 2021, Membrane env liposomes facilitate immunization with multivalent full-length HIV spikes, J. Virol., 95, e0000521, 10.1128/JVI.00005-21 Modery-Pawlowski, 2014, Heteromultivalent ligand-decoration for actively targeted nanomedicine, Biomaterials, 35, 2568, 10.1016/j.biomaterials.2013.12.047 Di Iorio, 2020, Surface modification with control over ligand density for the study of multivalent biological systems, Chemistry Open, 9, 53 Cavalcanti-Adam, 2007, Cell spreading and focal adhesion dynamics are regulated by spacing of integrin ligands, Biophys. J., 92, 2964, 10.1529/biophysj.106.089730 Chen, C., et al.,Quantification of available ligand density on the surface of targeted liposomal nanomedicines at the single-particle level. ACS Nano 16 (2022), p 6886−6897. Xu, 2012, Heterobivalent ligands target cell-surface receptor combinations in vivo, Proc. Natl. Acad. Sci. U.S.A., 109, 21295, 10.1073/pnas.1211762109 Takayama, 2021, Anticancer drug-loaded mesenchymal stem cells for targeted cancer therapy, J. Contr. Release, 329, 1090, 10.1016/j.jconrel.2020.10.037 Dos Santos Rodrigues, 2019, Functionalized liposomal nanoparticles for efficient gene delivery system to neuronal cell transfection, Int. J. Pharm., 566, 717, 10.1016/j.ijpharm.2019.06.026 Kang, 2020, Muscone/RI7217 co-modified upward messenger DTX liposomes enhanced permeability of blood-brain barrier and targeting glioma, Theranostics, 10, 4308, 10.7150/thno.41322 Narayanaswamy, 2021, Targeted delivery of combination therapeutics using monoclonal antibody 2C5-modified immunoliposomes for cancer therapy, Pharm. Res. (N. Y.), 38, 429, 10.1007/s11095-021-02986-1 Wang, 2021, Protein liposomes-mediated targeted acetylcholinesterase gene delivery for effective liver cancer therapy, J. Nanobiotechnol., 19, 31, 10.1186/s12951-021-00777-9 Kong, 2022, Multifunctional targeting liposomes of epirubicin plus resveratrol improved therapeutic effect on brain gliomas, Int. J. Nanomed., 17, 1087, 10.2147/IJN.S346948 Lee, 2017, Size-dependency of the surface ligand density of liposomes prepared by post-insertion, Biol. Pharm. Bull., 40, 1002, 10.1248/bpb.b16-00990 Munter, 2022, Unravelling heterogeneities in complement and antibody opsonization of individual liposomes as a function of surface architecture, Small, 18, e2106529, 10.1002/smll.202106529 Bannigan, 2021, Machine learning directed drug formulation development, Adv. Drug Deliv. Rev., 175, 10.1016/j.addr.2021.05.016 Macarron, 2011, Impact of high-throughput screening in biomedical research, Nat. Rev. Drug Discov., 10, 188, 10.1038/nrd3368 Rinkenauer, 2013, Parallel high-throughput screening of polymer vectors for nonviral gene delivery: evaluation of structure-property relationships of transfection, ACS Comb. Sci., 15, 475, 10.1021/co400025u Kumar, 2020, Efficient polymer-mediated delivery of gene-editing ribonucleoprotein payloads through combinatorial design, parallelized experimentation, and machine learning, ACS Nano, 14, 17626, 10.1021/acsnano.0c08549 Stavnsbjerg, C., et al.,Accelerated blood clearance and hypersensitivity by PEGylated liposomes containing TLR agonists. J. Contr. Release 342 (2022), pp 337-344. Engler, 2015, Hydrophilic polycarbonates: promising degradable alternatives to poly(ethylene glycol)-based stealth materials, Macromolecules, 48, 1673, 10.1021/acs.macromol.5b00156 Hou, 2021, Lipid nanoparticles for mRNA delivery, Nat. Rev. Mater., 6, 1078, 10.1038/s41578-021-00358-0 Ball, 2017, Achieving long-term stability of lipid nanoparticles: examining the effect of pH, temperature, and lyophilization, Int. J. Nanomed., 12, 305, 10.2147/IJN.S123062 Muramatsu, 2022, Lyophilization provides long-term stability for a lipid nanoparticle-formulated, nucleoside-modified mRNA vaccine, Mol. Ther., 30, 1941, 10.1016/j.ymthe.2022.02.001 Szwed, 2020, Biological response and cytotoxicity induced by lipid nanocapsules, J. Nanobiotechnol., 18, 5, 10.1186/s12951-019-0567-y Nikpoor, 2019, Cell cytotoxicity, immunostimulatory and antitumor effects of lipid content of liposomal delivery platforms in cancer immunotherapies. A comprehensive in-vivo and in-vitro study, Int. J. Pharm., 567, 10.1016/j.ijpharm.2019.118492 Paunovska, 2018, A direct comparison of in vitro and in vivo nucleic acid delivery mediated by hundreds of nanoparticles reveals a weak correlation, Nano Lett., 18, 2148, 10.1021/acs.nanolett.8b00432 Park, 2021, A logical network-based drug-screening platform for Alzheimer's disease representing pathological features of human brain organoids, Nat. Commun., 12, 280, 10.1038/s41467-020-20440-5